From the Divisions of Nuclear Medicine, and.
Endocrinology, Diabetology, and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy.
Clin Nucl Med. 2019 Feb;44(2):125-126. doi: 10.1097/RLU.0000000000002395.
We present a rare case of a 42-year-old man with a long history of von Hippel-Lindau disease that was scanned with Ga-DOTA-TOC PET/CT for suspicion of disease relapse. Ga-DOTA-TOC imaging demonstrated increased DOTA-TOC uptake in pancreas tail and intramedullary and extramedullary spinal hemangioblastomas, only some of which have already been highlighted at MRI examination. This case illustrates the significant role the Ga-labeled somatostatin receptor analogs PET/CT in the management of the von Hippel-Lindau disease.
我们报告了 1 例罕见病例,患者为 42 岁男性,患有 von Hippel-Lindau 病(VHL),病史较长,因疑似疾病复发而接受 Ga-DOTA-TOC PET/CT 检查。Ga-DOTA-TOC 成像显示胰尾和脊髓内、外髓质血管母细胞瘤摄取 DOTA-TOC 增加,其中一些已在 MRI 检查中被突出显示。该病例说明了 Ga 标记的生长抑素受体类似物 PET/CT 在 VHL 疾病管理中的重要作用。